Literature DB >> 11306549

A highly efficient ligand-regulated Cre recombinase mouse line shows that LoxP recombination is position dependent.

M Vooijs1, J Jonkers, A Berns.   

Abstract

Conditional gene inactivation using the Cre/loxP system is widely used, but the difficulty in properly regulating Cre expression remains one of the bottlenecks. One approach to regulate Cre activity utilizes a mutant estrogen hormone-binding domain (ERT) to keep Cre inactive unless the non-steroidal estrogen analog 4-hydroxytamoxifen (OHT) is present. Here we describe a mouse strain expressing Cre-ERT from the ubiquitously expressed ROSA26 (R26) locus. We demonstrate efficient temporal and spatial regulation of Cre recombination in vivo and in primary cells derived from these mice. We show the existence of marked differences in recombination frequencies between different substrates within the same cell. This has important consequences when concurrent switching of multiple alleles within the same cell is needed, and highlights one of the difficulties that may be encountered when using reporter mice as indicator strains.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11306549      PMCID: PMC1083861          DOI: 10.1093/embo-reports/kve064

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  33 in total

1.  Simplified mammalian DNA isolation procedure.

Authors:  P W Laird; A Zijderveld; K Linders; M A Rudnicki; R Jaenisch; A Berns
Journal:  Nucleic Acids Res       Date:  1991-08-11       Impact factor: 16.971

2.  Recombinase-mediated gene activation and site-specific integration in mammalian cells.

Authors:  S O'Gorman; D T Fox; G M Wahl
Journal:  Science       Date:  1991-03-15       Impact factor: 47.728

3.  Efficient selection for high-expression transfectants with a novel eukaryotic vector.

Authors:  H Niwa; K Yamamura; J Miyazaki
Journal:  Gene       Date:  1991-12-15       Impact factor: 3.688

4.  Temporal, spatial, and cell type-specific control of Cre-mediated DNA recombination in transgenic mice.

Authors:  A R Utomo; A Y Nikitin; W H Lee
Journal:  Nat Biotechnol       Date:  1999-11       Impact factor: 54.908

Review 5.  Engineering the mouse genome by site-specific recombination.

Authors:  D Metzger; R Feil
Journal:  Curr Opin Biotechnol       Date:  1999-10       Impact factor: 9.740

6.  Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1.

Authors:  B Sauer; N Henderson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

7.  Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient.

Authors:  S P Robinson; S M Langan-Fahey; D A Johnson; V C Jordan
Journal:  Drug Metab Dispos       Date:  1991 Jan-Feb       Impact factor: 3.922

8.  Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting.

Authors:  H Gu; Y R Zou; K Rajewsky
Journal:  Cell       Date:  1993-06-18       Impact factor: 41.582

9.  Requirement for a functional Rb-1 gene in murine development.

Authors:  A R Clarke; E R Maandag; M van Roon; N M van der Lugt; M van der Valk; M L Hooper; A Berns; H te Riele
Journal:  Nature       Date:  1992-09-24       Impact factor: 49.962

10.  Calcium regulation of growth and differentiation of mouse epidermal cells in culture.

Authors:  H Hennings; D Michael; C Cheng; P Steinert; K Holbrook; S H Yuspa
Journal:  Cell       Date:  1980-01       Impact factor: 41.582

View more
  155 in total

1.  Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells.

Authors:  A Loonstra; M Vooijs; H B Beverloo; B A Allak; E van Drunen; R Kanaar; A Berns; J Jonkers
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

2.  Enhanced efficiency through nuclear localization signal fusion on phage PhiC31-integrase: activity comparison with Cre and FLPe recombinase in mammalian cells.

Authors:  Susanne Andreas; Frieder Schwenk; Birgit Küter-Luks; Nicole Faust; Ralf Kühn
Journal:  Nucleic Acids Res       Date:  2002-06-01       Impact factor: 16.971

3.  Constitutive E2F1 overexpression delays endochondral bone formation by inhibiting chondrocyte differentiation.

Authors:  Blanca Scheijen; Marieke Bronk; Tiffany van der Meer; René Bernards
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

4.  Hedgehog signaling regulates sebaceous gland development.

Authors:  Mary Allen; Marina Grachtchouk; Hong Sheng; Vladimir Grachtchouk; Anna Wang; Lebing Wei; Jianhong Liu; Angel Ramirez; Daniel Metzger; Pierre Chambon; Jose Jorcano; Andrzej A Dlugosz
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

5.  Elimination of background recombination: somatic induction of Cre by combined transcriptional regulation and hormone binding affinity.

Authors:  Richard Kemp; Heather Ireland; Elizabeth Clayton; Carol Houghton; Louise Howard; Douglas J Winton
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

Review 6.  Conditional gene expression in the mouse inner ear using Cre-loxP.

Authors:  Brandon C Cox; Zhiyong Liu; Marcia M Mellado Lagarde; Jian Zuo
Journal:  J Assoc Res Otolaryngol       Date:  2012-04-24

7.  A Notch-dependent molecular circuitry initiates pancreatic endocrine and ductal cell differentiation.

Authors:  Hung Ping Shih; Janel L Kopp; Manbir Sandhu; Claire L Dubois; Philip A Seymour; Anne Grapin-Botton; Maike Sander
Journal:  Development       Date:  2012-06-06       Impact factor: 6.868

Review 8.  How insights from cardiovascular developmental biology have impacted the care of infants and children with congenital heart disease.

Authors:  Alvin J Chin; Jean-Pierre Saint-Jeannet; Cecilia W Lo
Journal:  Mech Dev       Date:  2012-05-26       Impact factor: 1.882

9.  Cre recombinase induces DNA damage and tetraploidy in the absence of loxP sites.

Authors:  Vaibhao C Janbandhu; Daniel Moik; Reinhard Fässler
Journal:  Cell Cycle       Date:  2013-11-26       Impact factor: 4.534

10.  Tie1 deletion inhibits tumor growth and improves angiopoietin antagonist therapy.

Authors:  Gabriela D'Amico; Emilia A Korhonen; Andrey Anisimov; Georgia Zarkada; Tanja Holopainen; René Hägerling; Friedemann Kiefer; Lauri Eklund; Raija Sormunen; Harri Elamaa; Rolf A Brekken; Ralf H Adams; Gou Young Koh; Pipsa Saharinen; Kari Alitalo
Journal:  J Clin Invest       Date:  2014-01-16       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.